Literature DB >> 15270857

Anti-actin IgA antibodies in severe coeliac disease.

A Granito1, P Muratori, F Cassani, G Pappas, L Muratori, D Agostinelli, L Veronesi, R Bortolotti, N Petrolini, F B Bianchi, U Volta.   

Abstract

Anti-actin IgA antibodies have been found in sera of coeliacs. Our aim was to define the prevalence and clinical significance of anti-actin IgA in coeliacs before and after gluten withdrawal. One hundred and two biopsy-proven coeliacs, 95 disease controls and 50 blood donors were studied. Anti-actin IgA were evaluated by different methods: (a) antimicrofilament positivity on HEp-2 cells and on cultured fibroblasts by immunofluorescence; (b) anti-actin positivity by enzyme-linked immuosorbent assay (ELISA); and (c) presence of the tubular/glomerular pattern of anti-smooth muscle antibodies on rat kidney sections by immunofluorescence. Antimicrofilament IgA were present in 27% of coeliacs and in none of the controls. Antimicrofilament antibodies were found in 25 of 54 (46%) coeliacs with severe villous atrophy and in three of 48 (6%) with mild damage (P < 0.0001). In the 20 patients tested, antimicrofilaments IgA disappeared after gluten withdrawal in accordance with histological recovery. Our study shows a significant correlation between antimicrofilament IgA and the severity of intestinal damage in untreated coeliacs. The disappearance of antimicrofilament IgA after gluten withdrawal predicts the normalization of intestinal mucosa and could be considered a useful tool in the follow-up of severe coeliac disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270857      PMCID: PMC1809109          DOI: 10.1111/j.1365-2249.2004.02541.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

Review 1.  The histopathology of coeliac disease: time for a standardized report scheme for pathologists.

Authors:  G Oberhuber; G Granditsch; H Vogelsang
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-10       Impact factor: 2.566

Review 2.  Celiac sprue.

Authors:  Richard J Farrell; Ciarán P Kelly
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

3.  Coeliac disease and secondary autoimmunity.

Authors:  D Schuppan; R Ciccocioppo
Journal:  Dig Liver Dis       Date:  2002-01       Impact factor: 4.088

4.  Smooth muscle antibodies and type 1 autoimmune hepatitis.

Authors:  Paolo Muratori; Luigi Muratori; Daniela Agostinelli; Georgios Pappas; Lorenza Veronesi; Alessandro Granito; Fabio Cassani; Paolo Terlizzi; Marco Lenzi; Francesco B Bianchi
Journal:  Autoimmunity       Date:  2002-12       Impact factor: 2.815

5.  Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease.

Authors:  A Zamanou; M Samiotaki; G Panayotou; L Margaritis; P Lymberi
Journal:  J Autoimmun       Date:  2003-06       Impact factor: 7.094

6.  Determination of anti-actin antibodies by a solid-phase immunoenzymatic assay and by indirect immunofluorescence technique.

Authors:  P Kurki
Journal:  Clin Immunol Immunopathol       Date:  1978-11

7.  Kinetic evidence for a monomer activation step in actin polymerization.

Authors:  J A Cooper; E L Buhle; S B Walker; T Y Tsong; T D Pollard
Journal:  Biochemistry       Date:  1983-04-26       Impact factor: 3.162

8.  Celiac disease in autoimmune cholestatic liver disorders.

Authors:  Umberto Volta; Luis Rodrigo; Alessandro Granito; Nunzio Petrolini; Paolo Muratori; Luigi Muratori; Antonio Linares; Lorenza Veronesi; Dolores Fuentes; Daniela Zauli; Francesco B Bianchi
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

9.  Classification of smooth muscle autoantibodies detected by immunofluorescence.

Authors:  G F Bottazzo; A Florin-Christensen; A Fairfax; G Swana; D Doniach; U Groeschel-Stewart
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

10.  Reactivity of smooth-muscle antibodies with F- and G-actin.

Authors:  P Andersen; J V Small; H K Andersen; A Sobieszek
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

View more
  12 in total

1.  Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease.

Authors:  Seiji Yokoyama; Kazuko Takada; Masatomo Hirasawa; Liyanage P Perera; Takachika Hiroi
Journal:  J Clin Immunol       Date:  2011-09-22       Impact factor: 8.317

Review 2.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

3.  Detection of autoantibodies against actin filaments in celiac disease.

Authors:  B Porcelli; F Ferretti; C Vindigni; C Scapellato; L Terzuoli
Journal:  J Clin Lab Anal       Date:  2013-01-04       Impact factor: 2.352

Review 4.  Serum markers in the clinical management of celiac disease.

Authors:  Marlou Adriaanse; Daniel A Leffler
Journal:  Dig Dis       Date:  2015-04-22       Impact factor: 2.404

5.  Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions.

Authors:  Anna Licata; Maria Cappello; Andrea Arini; Ada M Florena; Claudia Randazzo; Giuseppe Butera; Piero L Almasio; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2011-04-06       Impact factor: 3.397

6.  IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.

Authors:  Elena Bazzigaluppi; Barbara Parma; Giulia M Tronconi; Patrizia Corsin; Luca Albarello; Stefano Mora; Graziano Barera
Journal:  Ital J Pediatr       Date:  2010-03-18       Impact factor: 2.638

7.  Celiac Disease and Elevated Liver Enzymes: A Still Not Fully Defined Pathogenesis.

Authors:  Linda Beenet; Diego Tonesi
Journal:  J Clin Transl Hepatol       Date:  2021-04-07

8.  Diagnosis of celiac disease.

Authors:  Shinjini Bhatnagar; Nitya Tandon
Journal:  Indian J Pediatr       Date:  2006-08       Impact factor: 5.319

9.  Current guidelines for the management of celiac disease: A systematic review with comparative analysis.

Authors:  Alberto Raiteri; Alessandro Granito; Alice Giamperoli; Teresa Catenaro; Giulia Negrini; Francesco Tovoli
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

10.  Expression of Selected Genes and Circulating microRNAs in Patients with Celiac Disease.

Authors:  Elena Maria Domsa; Ioana Berindan-Neagoe; Livia Budisan; Cornelia Braicu; Ioana Para; Alina Ioana Tantau; Olga Hilda Orasan; Lidia Ciobanu; Teodora Atena Pop; Gabriela Adriana Filip; Nicoleta Leach; Vasile Negrean; Daniela Matei; Vasile Andreica
Journal:  Medicina (Kaunas)       Date:  2022-01-25       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.